{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:40:58Z","timestamp":1792183258485,"version":"4.4.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Springer Semin Immun"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1007\/s00281-005-0001-4","type":"journal-article","created":{"date-parts":[[2005,11,2]],"date-time":"2005-11-02T08:40:19Z","timestamp":1130920819000},"page":"286-298","source":"Crossref","is-referenced-by-count":88,"title":["C1 inhibitor: molecular and clinical aspects"],"prefix":"10.1007","volume":"27","author":[{"given":"Marco","family":"Cicardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Zingale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Zanichelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Pappalardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Cicardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,11,3]]},"reference":[{"key":"1_CR1","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/S0021-9258(19)63283-7","volume":"236","author":"J Pensky","year":"1961","unstructured":"Pensky J, Levy LR, Lepow IH (1961) Partial purification of a serum inhibitor of C1 esterase. J Biol Chem 236:1674\u20131679","journal-title":"J Biol Chem"},{"key":"1_CR2","first-page":"803","volume":"80","author":"OD Ratnoff","year":"1972","unstructured":"Ratnoff OD, Pensky J, Donaldson VH, Amir J (1972) The inhibitory properties of plasma against activated plasma thromboplastin antecedent (factor XIa) in hereditary angioneurotic edema. J Lab Clin Med 80:803\u2013809","journal-title":"J Lab Clin Med"},{"key":"1_CR3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1172\/JCI107967","volume":"55","author":"PC Harpel","year":"1975","unstructured":"Harpel PC, Cooper NR (1975) Studies on human plasma C1 inactivator\u2013enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin. J Clin Invest 55:593\u2013604","journal-title":"J Clin Invest"},{"key":"1_CR4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/bj1790449a","volume":"179","author":"RB Sim","year":"1979","unstructured":"Sim RB, Arlaud GJ, Colomb MG (1979) C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes. Biochem J 179:449\u2013457","journal-title":"Biochem J"},{"key":"1_CR5","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.4049\/jimmunol.126.5.1769","volume":"126","author":"RJ Ziccardi","year":"1981","unstructured":"Ziccardi RJ (1981) Activation of the early components of the classical complement pathway under physiologic conditions. J Immunol 126:1769\u20131773","journal-title":"J Immunol"},{"key":"1_CR6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1172\/JCI110470","volume":"69","author":"M Schapira","year":"1982","unstructured":"Schapira M, Scott CF, Colman RW (1982) Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. J Clin Invest 69:462\u2013468","journal-title":"J Clin Invest"},{"key":"1_CR7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1172\/JCI110743","volume":"71","author":"F Graaf van der","year":"1983","unstructured":"van der Graaf F, Koedam JA, Bouma BN (1983) Inactivation of kallikrein in human plasma. J Clin Invest 71:149\u2013158","journal-title":"J Clin Invest"},{"key":"1_CR8","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI111360","volume":"73","author":"A Agostini de","year":"1984","unstructured":"de Agostini A, Lijnen HR, Pixley RA, Colman RW, Schapira M (1984) Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor. J Clin Invest 73:1542\u20131549","journal-title":"J Clin Invest"},{"key":"1_CR9","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1016\/S0021-9258(18)89258-4","volume":"260","author":"PC Harpel","year":"1985","unstructured":"Harpel PC, Lewin MF, Kaplan AP (1985) Distribution of plasma kallikrein between C-1 inactivator and alpha 2-macroglobulin in plasma utilizing a new assay for alpha 2-macroglobulin\u2013kallikrein complexes. J Biol Chem 260:4257\u20134263","journal-title":"J Biol Chem"},{"key":"1_CR10","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0021-9258(18)89653-3","volume":"260","author":"RA Pixley","year":"1985","unstructured":"Pixley RA, Schapira M, Colman RW (1985) The regulation of human factor XIIa by plasma proteinase inhibitors. J Biol Chem 260:1723\u20131729","journal-title":"J Biol Chem"},{"key":"1_CR11","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood.V69.6.1600.1600","volume":"69","author":"NA Booth","year":"1987","unstructured":"Booth NA, Walker E, Maughan R, Bennett B (1987) Plasminogen activator in normal subjects after exercise and venous occlusion: t-PA circulates as complexes with C1-inhibitor and PAI-1. Blood 69:1600\u20131604","journal-title":"Blood"},{"key":"1_CR12","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.4049\/jimmunol.165.5.2637","volume":"165","author":"M Matsushita","year":"2000","unstructured":"Matsushita M, Thiel S, Jensenius JC, Terai I, Fujita T (2000) Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol 165:2637\u20132642","journal-title":"J Immunol"},{"key":"1_CR13","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1084\/jem.194.11.1609","volume":"194","author":"H Jiang","year":"2001","unstructured":"Jiang H, Wagner E, Zhang H, Frank MM (2001) Complement 1 inhibitor is a regulator of the alternative complement pathway. J Exp Med 194:1609\u20131616","journal-title":"J Exp Med"},{"key":"1_CR14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00001721-200106000-00005","volume":"12","author":"M Cugno","year":"2001","unstructured":"Cugno M, Bos I, Lubbers Y, Hack CE, Agostoni A (2001) In vitro interaction of C1-inhibitor with thrombin. Blood Coagul Fibrinolysis 12:253\u2013260","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1_CR15","doi-asserted-by":"crossref","first-page":"8876","DOI":"10.1021\/bi00100a022","volume":"30","author":"PA Patston","year":"1991","unstructured":"Patston PA, Gettins P, Beechem J, Schapira M (1991) Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate. Biochemistry 30:8876\u20138882","journal-title":"Biochemistry"},{"key":"1_CR16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/BST0330321","volume":"33","author":"DA Lomas","year":"2005","unstructured":"Lomas DA, Belorgey D, Mallya M, Miranda E, Kinghorn KJ, Sharp LK et al (2005) Molecular mousetraps and the serpinopathies(1). Biochem Soc Trans 33:321\u2013330","journal-title":"Biochem Soc Trans"},{"key":"1_CR17","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.4049\/jimmunol.153.8.3648","volume":"153","author":"M Coutinho","year":"1994","unstructured":"Coutinho M, Aulak KS, Davis AE III (1994) Functional analysis of the serpin domain of C1 inhibitor. J Immunol 153:3648\u20133654","journal-title":"J Immunol"},{"key":"1_CR18","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1021\/bi00363a018","volume":"25","author":"SC Bock","year":"1986","unstructured":"Bock SC, Skriver K, Nielsen E, Thogersen HC, Wiman B, Donaldson VH et al (1986) Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization. Biochemistry 25:4292\u20134301","journal-title":"Biochemistry"},{"key":"1_CR19","doi-asserted-by":"crossref","first-page":"29463","DOI":"10.1074\/jbc.M302977200","volume":"278","author":"IG Bos","year":"2003","unstructured":"Bos IG, Lubbers YT, Roem D, Abrahams JP, Hack CE, Eldering E (2003) The functional integrity of the serpin domain of C1-inhibitor depends on the unique N-terminal domain, as revealed by a pathological mutant. J Biol Chem 278:29463\u201329470","journal-title":"J Biol Chem"},{"key":"1_CR20","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.4049\/jimmunol.171.5.2594","volume":"171","author":"D Liu","year":"2003","unstructured":"Liu D, Cai S, Gu X, Scafidi J, Wu X, Davis AE III (2003) C1 inhibitor prevents endotoxin shock via a direct interaction with lipopolysaccharide. J Immunol 171:2594\u20132601","journal-title":"J Immunol"},{"key":"1_CR21","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1182\/blood-2004-05-1963","volume":"105","author":"D Liu","year":"2005","unstructured":"Liu D, Zhang D, Scafidi J, Wu X, Cramer CC, Davis AE III (2005) C1 inhibitor prevents Gram-negative bacterial lipopolysaccharide-induced vascular permeability. Blood 105:2350\u20132355","journal-title":"Blood"},{"key":"1_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1152\/physrev.1999.79.1.181","volume":"79","author":"D Vestweber","year":"1999","unstructured":"Vestweber D, Blanks JE (1999) Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev 79:181\u2013213","journal-title":"Physiol Rev"},{"key":"1_CR23","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.4049\/jimmunol.171.9.4786","volume":"171","author":"S Cai","year":"2003","unstructured":"Cai S, Davis AE III (2003) Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion. J Immunol 171:4786\u20134791","journal-title":"J Immunol"},{"key":"1_CR24","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.4049\/jimmunol.174.10.6462","volume":"174","author":"S Cai","year":"2005","unstructured":"Cai S, Dole VS, Bergmeier W, Scafidi J, Feng H, Wagner DD et al (2005) A direct role for C1 inhibitor in regulation of leukocyte adhesion. J Immunol 174:6462\u20136466","journal-title":"J Immunol"},{"key":"1_CR25","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrg907","volume":"3","author":"DA Lomas","year":"2002","unstructured":"Lomas DA, Carrell RW (2002) Serpinopathies and the conformational dementias. Nat Rev Genet 3:759\u2013768","journal-title":"Nat Rev Genet"},{"key":"1_CR26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0140-6736(97)02073-4","volume":"350","author":"RW Carrell","year":"1997","unstructured":"Carrell RW, Lomas DA (1997) Conformational disease. Lancet 350:134\u2013138","journal-title":"Lancet"},{"key":"1_CR27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/357605a0","volume":"357","author":"DA Lomas","year":"1992","unstructured":"Lomas DA, Evans DL, Finch JT, Carrell RW (1992) The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 357:605\u2013607","journal-title":"Nature"},{"key":"1_CR28","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1164\/ajrccm\/150.6_Pt_2.S171","volume":"150","author":"RW Carrell","year":"1994","unstructured":"Carrell RW, Whisstock J, Lomas DA (1994) Conformational changes in serpins and the mechanism of alpha 1-antitrypsin deficiency [published erratum appears in Am J Respir Crit Care Med 1995 Mar;151(3 Pt 1):926]. Am J Respir Crit Care Med 150:S171\u2013S175","journal-title":"Am J Respir Crit Care Med"},{"key":"1_CR29","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1056\/NEJM198309223091203","volume":"309","author":"MC Owen","year":"1983","unstructured":"Owen MC, Brennan SO, Lewis JH, Carrell RW (1983) Mutation of antitrypsin to antithrombin. Alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder. N Engl J Med 309:694\u2013698","journal-title":"N Engl J Med"},{"key":"1_CR30","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1021\/bi010100x","volume":"40","author":"FC Peterson","year":"2001","unstructured":"Peterson FC, Gettins PG (2001) Insight into the mechanism of serpin-proteinase inhibition from 2D [1H\u201315N] NMR studies of the 69\u00a0kDa alpha 1-proteinase inhibitor Pittsburgh\u2013trypsin covalent complex. Biochemistry 40:6284\u20136292","journal-title":"Biochemistry"},{"key":"1_CR31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/BF00211016","volume":"94","author":"DS Millar","year":"1994","unstructured":"Millar DS, Wacey AI, Ribando J, Melissari E, Laursen B, Woods P et al (1994) Three novel missense mutations in the antithrombin III (AT3) gene causing recurrent venous thrombosis. Hum Genet 94:509\u2013512","journal-title":"Hum Genet"},{"key":"1_CR32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1042\/bst0300089","volume":"30","author":"DA Lomas","year":"2002","unstructured":"Lomas DA, Lourbakos A, Cumming SA, Belorgey D (2002) Hypersensitive mousetraps, alpha1-antitrypsin deficiency and dementia. Biochem Soc Trans 30:89\u201392","journal-title":"Biochem Soc Trans"},{"key":"1_CR33","first-page":"37","volume":"31","author":"VH Donaldson","year":"1963","unstructured":"Donaldson VH, Evans RR (1963) A Biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C\u2032 1-esterase. Am J Sci 31:37\u201344","journal-title":"Am J Sci"},{"key":"1_CR34","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1073\/pnas.83.10.3161","volume":"83","author":"AE Davis III","year":"1986","unstructured":"Davis AE III, Whitehead AS, Harrison RA, Dauphinais A, Bruns GA, Cicardi M et al (1986) Human inhibitor of the first component of complement, C1: characterization of cDNA clones and localization of the gene to chromosome 11. Proc Natl Acad Sci U S A 83:3161\u20133165","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0378-1119(86)90230-1","volume":"42","author":"M Tosi","year":"1986","unstructured":"Tosi M, Duponchel C, Bourgarel P, Colomb M, Meo T (1986) Molecular cloning of human C1 inhibitor: sequence homologies with alpha 1-antitrypsin and other members of the serpins superfamily. Gene 42:265\u2013272","journal-title":"Gene"},{"key":"1_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/humu.20112","volume":"25","author":"L Kalmar","year":"2005","unstructured":"Kalmar L, Hegedus T, Farkas H, Nagy M, Tordai A (2005) HAEdb: a novel interactive, locus-specific mutation database for the C1 inhibitor gene. Hum Mutat 25:1\u20135","journal-title":"Hum Mutat"},{"key":"1_CR37","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/archinte.1917.00090060014002","volume":"20","author":"JR Crowder","year":"1917","unstructured":"Crowder JR, Crowder TR (1917) Five generations of angioneurotic edema. Arch Inter Med 20:840\u2013852","journal-title":"Arch Inter Med"},{"key":"1_CR38","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1172\/JCI113252","volume":"80","author":"M Cicardi","year":"1987","unstructured":"Cicardi M, Igarashi T, Kim MS, Frangi D, Agostoni A, Davis AE III (1987) Restriction fragment length polymorphism of the C1 inhibitor gene in hereditary angioneurotic edema. J Clin Invest 80:1640\u20131643","journal-title":"J Clin Invest"},{"key":"1_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198707023170101","volume":"317","author":"D Stoppa-Lyonnet","year":"1987","unstructured":"Stoppa-Lyonnet D, Tosi M, Laurent J, Sobel A, Lagrue G, Meo T (1987) Altered C1 inhibitor genes in type I hereditary angioedema. N Engl J Med 317:1\u20136","journal-title":"N Engl J Med"},{"key":"1_CR40","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nrg910","volume":"3","author":"JL Badano","year":"2002","unstructured":"Badano JL, Katsanis N (2002) Beyond Mendel: an evolving view of human genetic disease transmission. Nat Rev Genet 3:779\u2013789","journal-title":"Nat Rev Genet"},{"key":"1_CR41","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.jaci.2004.06.047","volume":"114","author":"A Agostoni","year":"2004","unstructured":"Agostoni A, Aygoren-Pursun E, Binkley KE, Blanch A, Bork K, Bouillet L et al (2004) Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114:S51\u2013S131","journal-title":"J Allergy Clin Immunol"},{"key":"1_CR42","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1172\/JCI105756","volume":"47","author":"MR Klemperer","year":"1968","unstructured":"Klemperer MR, Donaldson VH, Rosen FS (1968) Effect of C\u20321 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema. J Clin Invest 47:604\u2013611","journal-title":"J Clin Invest"},{"key":"1_CR43","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1172\/JCI106022","volume":"48","author":"VH Donaldson","year":"1969","unstructured":"Donaldson VH, Ratnoff OD, Dias Da Silva W, Rosen FS (1969) Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization. J Clin Invest 48:642\u2013653","journal-title":"J Clin Invest"},{"key":"1_CR44","first-page":"174","volume":"90","author":"VH Donaldson","year":"1977","unstructured":"Donaldson VH, Rosen FS, Bing DH (1977) Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma. Trans Assoc Am Physicians 90:174\u2013183","journal-title":"Trans Assoc Am Physicians"},{"key":"1_CR45","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJM198305053081802","volume":"308","author":"M Schapira","year":"1983","unstructured":"Schapira M, Silver LD, Scott CF, Schmaier AH, Prograis LJ Jr, Curd JG et al (1983) Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema. N Engl J Med 308:1050\u20131053","journal-title":"N Engl J Med"},{"key":"1_CR46","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1084\/jem.152.3.742","volume":"152","author":"JG Curd","year":"1980","unstructured":"Curd JG, Prograis LJ Jr, Cochrane CG (1980) Detection of active kallikrein in induced blister fluids of hereditary angioedema patients. J Exp Med 152:742\u2013747","journal-title":"J Exp Med"},{"key":"1_CR47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0091-6749(83)90052-0","volume":"72","author":"T Fields","year":"1983","unstructured":"Fields T, Ghebrehiwet B, Kaplan AP (1983) Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of \u201cspontaneous\u201d formation of bradykinin. J Allergy Clin Immunol 72:54\u201360","journal-title":"J Allergy Clin Immunol"},{"key":"1_CR48","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.jaci.2004.06.047","volume":"114","author":"A Agostoni","year":"2004","unstructured":"Agostoni A, Aygoren-Pursun E, Binkley KE, Blanch A, Bork K, Bouillet L et al (2004) Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114:S51\u2013S131","journal-title":"J Allergy Clin Immunol"},{"key":"1_CR49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.transci.2003.08.012","volume":"29","author":"AE Davis","year":"2003","unstructured":"Davis AE (2003) The pathogenesis of hereditary angioedema. Transfus Apher Sci 29:195\u2013203","journal-title":"Transfus Apher Sci"},{"key":"1_CR50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clim.2004.05.007","volume":"114","author":"AE Davis III","year":"2005","unstructured":"Davis AE III (2005) The pathophysiology of hereditary angioedema. Clin Immunol 114:3\u20139","journal-title":"Clin Immunol"},{"key":"1_CR51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2249.1994.tb06009.x","volume":"95","author":"LR Shoemaker","year":"1994","unstructured":"Shoemaker LR, Schurman SJ, Donaldson VH, Davis AE III (1994) Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities. Clin Exp Immunol 95:22\u201328","journal-title":"Clin Exp Immunol"},{"key":"1_CR52","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","volume":"351","author":"J Nussberger","year":"1998","unstructured":"Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A (1998) Plasma bradykinin in angio-oedema. Lancet 351:1693\u20131697","journal-title":"Lancet"},{"key":"1_CR53","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0091-6749(99)70030-8","volume":"104","author":"J Nussberger","year":"1999","unstructured":"Nussberger J, Cugno M, Cicardi M, Agostoni A (1999) Local bradykinin generation in hereditary angioedema. J Allergy Clin Immunol 104:1321\u20131322","journal-title":"J Allergy Clin Immunol"},{"key":"1_CR54","doi-asserted-by":"crossref","first-page":"983","DOI":"10.4049\/jimmunol.159.2.983","volume":"159","author":"R Zahedi","year":"1997","unstructured":"Zahedi R, Wisnieski J, Davis AE III (1997) Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases. J Immunol 159:983\u2013988","journal-title":"J Immunol"},{"key":"1_CR55","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1172\/JCI200214211","volume":"109","author":"ED Han","year":"2002","unstructured":"Han ED, MacFarlane RC, Mulligan AN, Scafidi J, Davis AE III (2002) Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. J Clin Invest 109:1057\u20131063","journal-title":"J Clin Invest"},{"key":"1_CR56","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-2478(03)00130-5","volume":"89","author":"ED Han Lee","year":"2003","unstructured":"Han Lee ED, Pappalardo E, Scafidi J, Davis AE III (2003) Approaches toward reversal of increased vascular permeability in C1 inhibitor deficient mice. Immunol Lett 89:155\u2013160","journal-title":"Immunol Lett"},{"key":"1_CR57","doi-asserted-by":"crossref","unstructured":"Icatibant: HOE 140, JE 049, JE049. Drugs R D (2004) 5:343\u2013348","DOI":"10.2165\/00126839-200405060-00006"},{"key":"1_CR58","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1473-0502(03)00170-8","volume":"29","author":"A Williams","year":"2003","unstructured":"Williams A, Baird LG (2003) DX-88 and HAE: a developmental perspective. Transfus Apher Sci 29:255\u2013258","journal-title":"Transfus Apher Sci"},{"key":"1_CR59","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1016\/j.jaci.2004.12.585","volume":"115","author":"M Cicardi","year":"2005","unstructured":"Cicardi M, Morrison J, Baird L, Williams A (2005) Plasma kallikrein inhibition: a viable method of treating laryngeal edema secondary to hereditary angioedema (HAE). J Allergy Clin Immunol 115:S203","journal-title":"J Allergy Clin Immunol"},{"key":"1_CR60","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00005792-199207000-00003","volume":"71","author":"A Agostoni","year":"1992","unstructured":"Agostoni A, Cicardi M (1992) Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore) 71:206\u2013215","journal-title":"Medicine (Baltimore)"},{"key":"1_CR61","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.transci.2003.08.007","volume":"29","author":"K Bork","year":"2003","unstructured":"Bork K, Ressel N (2003) Sudden upper airway obstruction in patients with hereditary angioedema. Transfus Apher Sci 29:235\u2013238","journal-title":"Transfus Apher Sci"},{"key":"1_CR62","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2249.2005.02726.x","volume":"139","author":"MM Gompels","year":"2005","unstructured":"Gompels MM, Lock RJ, Abinun M, Bethune CA, Davies G, Grattan C et al (2005) C1 inhibitor deficiency: consensus document. Clin Exp Immunol 139:379\u2013394","journal-title":"Clin Exp Immunol"},{"key":"1_CR63","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jaci.2004.06.043","volume":"114","author":"T Bowen","year":"2004","unstructured":"Bowen T, Cicardi M, Farkas H, Bork K, Kreuz W, Zingale L et al (2004) Canadian 2003 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema. J Allergy Clin Immunol 114:629\u2013637","journal-title":"J Allergy Clin Immunol"},{"key":"1_CR64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1473-0502(03)00164-2","volume":"29","author":"M Cicardi","year":"2003","unstructured":"Cicardi M, Zingale L (2003) How do we treat patients with hereditary angioedema. Transfus Apher Sci 29:221\u2013227","journal-title":"Transfus Apher Sci"},{"key":"1_CR65","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1016\/j.jaci.2004.12.820","volume":"115","author":"J Nuijens","year":"2005","unstructured":"Nuijens J, Verdonk R, Van Doorn M, Burggraaf K, Cohen A, Choi G et al (2005) Clinical studies of recombinant human C1 inhibitor in subjects with hereditary angioedema. J Allergy Clin Immunol 115:S202","journal-title":"J Allergy Clin Immunol"},{"key":"1_CR66","unstructured":"Bork K, Frank J, Kreuz W, Dong L, Rosenkranz B, Knolle J. Novel approach to treatment of hereditary angioedema with Icatibant, a bradykinin receptor antagonist. IV C1 inhibitor deficiency workshop, Budapest 29 April\u20131 May 2005; Abstract Book:19"},{"key":"1_CR67","first-page":"299","volume":"44","author":"A Agostoni","year":"1980","unstructured":"Agostoni A, Bergamaschini L, Martignoni G, Cicardi M, Marasini B (1980) Treatment of acute attacks of hereditary angioedema with C1-inhibitor concentrate. Ann Allergy 44:299\u2013301","journal-title":"Ann Allergy"},{"key":"1_CR68","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJM198003063021002","volume":"302","author":"JE Gadek","year":"1980","unstructured":"Gadek JE, Hosea SW, Gelfand JA, Santaella M, Wickerhauser M, Triantaphyllopoulos DC et al (1980) Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. N Engl J Med 302:542\u2013546","journal-title":"N Engl J Med"},{"key":"1_CR69","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJM199606203342503","volume":"334","author":"AT Waytes","year":"1996","unstructured":"Waytes AT, Rosen FS, Frank MM (1996) Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N Engl J Med 334:1630\u20131634","journal-title":"N Engl J Med"},{"key":"1_CR70","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archinte.161.5.714","volume":"161","author":"K Bork","year":"2001","unstructured":"Bork K, Barnstedt SE (2001) Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med 161:714\u2013718","journal-title":"Arch Intern Med"},{"key":"1_CR71","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0002-9440(10)63830-8","volume":"162","author":"NC Riedemann","year":"2003","unstructured":"Riedemann NC, Ward PA (2003) Complement in ischemia reperfusion injury. Am J Pathol 162:363\u2013367","journal-title":"Am J Pathol"},{"key":"1_CR72","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1472-8206.2001.00040.x","volume":"15","author":"T Monsinjon","year":"2001","unstructured":"Monsinjon T, Richard V, Fontaine M (2001) Complement and its implications in cardiac ischemia\/reperfusion: strategies to inhibit complement. Fundam Clin Pharmacol 15:293\u2013306","journal-title":"Fundam Clin Pharmacol"},{"key":"1_CR73","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00024382-200405000-00002","volume":"21","author":"TV Arumugam","year":"2004","unstructured":"Arumugam TV, Shiels IA, Woodruff TM, Granger DN, Taylor SM (2004) The role of the complement system in ischemia\u2013reperfusion injury. Shock 21:401\u2013409","journal-title":"Shock"},{"key":"1_CR74","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000077255","volume":"36","author":"D Inderbitzin","year":"2004","unstructured":"Inderbitzin D, Beldi G, Avital I, Vinci G, Candinas D (2004) Local and remote ischemia\u2013reperfusion injury is mitigated in mice overexpressing human C1 inhibitor. Eur Surg Res 36:142\u2013147","journal-title":"Eur Surg Res"},{"key":"1_CR75","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/micr.10210","volume":"23","author":"GA Toomayan","year":"2003","unstructured":"Toomayan GA, Chen LE, Jiang HX, Qi WN, Seaber AV, Frank MM et al (2003) C1-esterase inhibitor and a novel peptide inhibitor improve contractile function in reperfused skeletal muscle. Microsurgery 23:561\u2013567","journal-title":"Microsurgery"},{"key":"1_CR76","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-3083.2002.01173.x","volume":"56","author":"EW Nielsen","year":"2002","unstructured":"Nielsen EW, Mollnes TE, Harlan JM, Winn RK (2002) C1-inhibitor reduces the ischaemia\u2013reperfusion injury of skeletal muscles in mice after aortic cross-clamping. Scand J Immunol 56:588\u2013592","journal-title":"Scand J Immunol"},{"key":"1_CR77","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/01.CIR.91.2.393","volume":"91","author":"M Buerke","year":"1995","unstructured":"Buerke M, Murohara T, Lefer AM (1995) Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion [see comments]. Circulation 91:393\u2013402","journal-title":"Circulation"},{"key":"1_CR78","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.CIR.95.3.701","volume":"95","author":"G Horstick","year":"1997","unstructured":"Horstick G, Heimann A, Gotze O, Hafner G, Berg O, Boehmer P et al (1997) Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion. Circulation 95:701\u2013708","journal-title":"Circulation"},{"key":"1_CR79","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0022-3565(24)37603-7","volume":"286","author":"M Buerke","year":"1998","unstructured":"Buerke M, Prufer D, Dahm M, Oelert H, Meyer J, Darius H (1998) Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury. J Pharmacol Exp Ther 286:429\u2013438","journal-title":"J Pharmacol Exp Ther"},{"key":"1_CR80","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1161\/hc5001.100835","volume":"104","author":"G Horstick","year":"2001","unstructured":"Horstick G, Berg O, Heimann A, Gotze O, Loos M, Hafner G et al (2001) Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: dose-related beneficial versus detrimental effects. Circulation 104:3125\u20133131","journal-title":"Circulation"},{"key":"1_CR81","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s001340050629","volume":"24","author":"R Bauernschmitt","year":"1998","unstructured":"Bauernschmitt R, Bohrer H, Hagl S (1998) Rescue therapy with C1-esterase inhibitor concentrate after emergency coronary surgery for failed PTCA. Intensive Care Med 24:635\u2013638","journal-title":"Intensive Care Med"},{"key":"1_CR82","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1053\/euhj.2002.3191","volume":"23","author":"C Zwaan de","year":"2002","unstructured":"de Zwaan C, Kleine AH, Diris JH, Glatz JF, Wellens HJ, Strengers PF et al (2002) Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarction. Eur Heart J 23:1670\u20131677","journal-title":"Eur Heart J"},{"key":"1_CR83","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0002-9440(10)63744-3","volume":"164","author":"MG Simoni De","year":"2004","unstructured":"De Simoni MG, Rossi E, Storini C, Pizzimenti S, Echart C, Bergamaschini L (2004) The powerful neuroprotective action of C1-inhibitor on brain ischemia\u2013reperfusion injury does not require C1q. Am J Pathol 164:1857\u20131863","journal-title":"Am J Pathol"},{"key":"1_CR84","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.WCB.0000046146.31247.A1","volume":"23","author":"MG Simoni De","year":"2003","unstructured":"De Simoni MG, Storini C, Barba M, Catapano L, Arabia AM, Rossi E et al (2003) Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia. J Cereb Blood Flow Metab 23:232\u2013239","journal-title":"J Cereb Blood Flow Metab"},{"key":"1_CR85","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nbd.2004.11.001","volume":"19","author":"C Storini","year":"2005","unstructured":"Storini C, Rossi E, Marrella V, Distaso M, Veerhuis R, Vergani C et al (2005) C1-inhibitor protects against brain ischemia\u2013reperfusion injury via inhibition of cell recruitment and inflammation. Neurobiol Dis 19:10\u201317","journal-title":"Neurobiol Dis"},{"key":"1_CR86","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0006-8993(99)01740-0","volume":"838","author":"A Heimann","year":"1999","unstructured":"Heimann A, Takeshima T, Horstick G, Kempski O (1999) C1-esterase inhibitor reduces infarct volume after cortical vein occlusion. Brain Res 838:210\u2013213","journal-title":"Brain Res"},{"key":"1_CR87","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1227\/01.NEU.0000043710.61233.B4","volume":"52","author":"N Akita","year":"2003","unstructured":"Akita N, Nakase H, Kaido T, Kanemoto Y, Sakaki T (2003) Protective effect of C1 esterase inhibitor on reperfusion injury in the rat middle cerebral artery occlusion model. Neurosurgery 52:395\u2013400 (discussion-1)","journal-title":"Neurosurgery"},{"key":"1_CR88","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/14017430410028618","volume":"38","author":"J Heikkinen","year":"2004","unstructured":"Heikkinen J, Koskenkari J, Kaakinen T, Dahlbacka S, Kiviluoma K, Salomaki T et al (2004) Apotransferrin, C1-esterase inhibitor, and alpha 1-acid glycoprotein for cerebral protection during experimental hypothermic circulatory arrest. Scand Cardiovasc J 38:178\u2013186","journal-title":"Scand Cardiovasc J"},{"key":"1_CR89","doi-asserted-by":"crossref","first-page":"S547","DOI":"10.1111\/j.1432-2277.2000.tb02101.x","volume":"13","author":"TG Lehmann","year":"2000","unstructured":"Lehmann TG, Heger M, Munch S, Kirschfink M, Klar E (2000) In vivo microscopy reveals that complement inhibition by C1-esterase inhibitor reduces ischemia\/reperfusion injury in the liver. Transpl Int 13:S547\u2013S550","journal-title":"Transpl Int"},{"key":"1_CR90","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0003-4975(01)03235-0","volume":"73","author":"M Scherer","year":"2002","unstructured":"Scherer M, Demertzis S, Langer F, Moritz A, Schafers HJ (2002) C1-esterase inhibitor reduces reperfusion injury after lung transplantation. Ann Thorac Surg 73:233\u2013238 (discussion 8\u20139)","journal-title":"Ann Thorac Surg"},{"key":"1_CR91","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0041-1345(00)02277-6","volume":"33","author":"L Bergamaschini","year":"2001","unstructured":"Bergamaschini L, Gatti S, Caccamo L, Prato P, Latham L, Trezza P et al (2001) C1 inhibitor potentiates the protective effect of organ preservation solution on endothelial cells during cold storage. Transplant Proc 33:939\u2013941","journal-title":"Transplant Proc"},{"key":"1_CR92","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1365-2249.2001.01695.x","volume":"126","author":"L Bergamaschini","year":"2001","unstructured":"Bergamaschini L, Gobbo G, Gatti S, Caccamo L, Prato P, Maggioni M et al (2001) Endothelial targeting with C1-inhibitor reduces complement activation in vitro and during ex vivo reperfusion of pig liver. Clin Exp Immunol 126:412\u2013420","journal-title":"Clin Exp Immunol"},{"key":"1_CR93","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/infdis\/151.6.1019","volume":"151","author":"ES Kalter","year":"1985","unstructured":"Kalter ES, Daha MR, ten Cate JW, Verhoef J, Bouma BN (1985) Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock. J Infect Dis 151:1019\u20131027","journal-title":"J Infect Dis"},{"key":"1_CR94","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1182\/blood.V72.6.1841.1841","volume":"72","author":"JH Nuijens","year":"1988","unstructured":"Nuijens JH, Huijbregts CC, Eerenberg-Belmer AJ, Abbink JJ, Strack van Schijndel RJ, Felt-Bersma RJ et al (1988) Quantification of plasma factor XIIa-Cl(\u2212)-inhibitor and kallikrein-Cl(\u2212)-inhibitor complexes in sepsis. Blood 72:1841\u20131848","journal-title":"Blood"},{"key":"1_CR95","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1128\/IAI.61.10.4293-4301.1993","volume":"61","author":"JP Boer de","year":"1993","unstructured":"de Boer JP, Creasey AA, Chang A, Roem D, Eerenberg AJ, Hack CE et al (1993) Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern. Infect Immun 61:4293\u20134301","journal-title":"Infect Immun"},{"key":"1_CR96","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4049\/jimmunol.160.1.475","volume":"160","author":"PM Jansen","year":"1992","unstructured":"Jansen PM, Eisele B, de Jong IW, Chang A, Delvos U, Taylor FB Jr et al (1992) Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock. J Immunol 160:475\u2013484","journal-title":"J Immunol"},{"key":"1_CR97","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood.V87.6.2337.bloodjournal8762337","volume":"87","author":"PM Jansen","year":"1996","unstructured":"Jansen PM, Pixley RA, Brouwer M, de Jong IW, Chang AC, Hack CE et al (1996) Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase. Blood 87:2337\u20132344","journal-title":"Blood"},{"key":"1_CR98","doi-asserted-by":"crossref","first-page":"976","DOI":"10.4049\/jimmunol.159.2.976","volume":"159","author":"MB Fischer","year":"1997","unstructured":"Fischer MB, Prodeus AP, Nicholson-Weller A, Ma M, Murrow J, Reid RR et al (1997) Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. J Immunol 159:976\u2013982","journal-title":"J Immunol"},{"key":"1_CR99","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0140-6736(92)91705-D","volume":"339","author":"CE Hack","year":"1992","unstructured":"Hack CE, Voerman HJ, Eisele B, Keinecke HO, Nuijens JH, Eerenberg AJ et al (1992) C1-esterase inhibitor substitution in sepsis. Lancet 339:378","journal-title":"Lancet"},{"key":"1_CR100","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s001340051000","volume":"25","author":"G Marx","year":"1999","unstructured":"Marx G, Nashan B, Cobas Meyer M, Vangerow B, Schlitt HJ, Ziesing S et al (1999) Septic shock after liver transplantation for Caroli\u2019s disease: clinical improvement after treatment with C1-esterase inhibitor. Intensive Care Med 25:1017\u20131020","journal-title":"Intensive Care Med"},{"key":"1_CR101","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1097\/00003246-200208000-00008","volume":"30","author":"C Caliezi","year":"2002","unstructured":"Caliezi C, Zeerleder S, Redondo M, Regli B, Rothen HU, Zurcher-Zenklusen R et al (2002) C1-inhibitor in patients with severe sepsis and septic shock: beneficial effect on renal dysfunction. Crit Care Med 30:1722\u20131728","journal-title":"Crit Care Med"},{"key":"1_CR102","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1385\/IJGC:25:2:113","volume":"25","author":"P Kruse","year":"1999","unstructured":"Kruse P, Hage E, Lasson A (1999) Proteases and protease inhibitors in taurocholate-induced acute pancreatitis in rats. Int J Pancreatol 25:113\u2013121","journal-title":"Int J Pancreatol"},{"key":"1_CR103","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gut.40.4.531","volume":"40","author":"H Yamaguchi","year":"1997","unstructured":"Yamaguchi H, Weidenbach H, Luhrs H, Lerch MM, Dickneite G, Adler G (1997) Combined treatment with C1 esterase inhibitor and antithrombin III improves survival in severe acute experimental pancreatitis. Gut 40:531\u2013535","journal-title":"Gut"},{"key":"1_CR104","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF02788538","volume":"17","author":"C Niederau","year":"1995","unstructured":"Niederau C, Brinsa R, Niederau M, Luthen R, Strohmeyer G, Ferrell LD (1995) Effects of C1-esterase inhibitor in three models of acute pancreatitis. Int J Pancreatol 17:189\u2013196","journal-title":"Int J Pancreatol"},{"key":"1_CR105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF02924443","volume":"13","author":"S Vesentini","year":"1993","unstructured":"Vesentini S, Benetti L, Bassi C, Bonora A, Campedelli A, Zamboni G et al (1993) Effects of choline-esterase inhibitor in experimental acute pancreatitis in rats. Preliminary results. Int J Pancreatol 13:217\u2013220","journal-title":"Int J Pancreatol"},{"key":"1_CR106","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3109\/00365528608996414","volume":"21","author":"TE Ruud","year":"1986","unstructured":"Ruud TE, Aasen AO, Pillgram-Larsen J, Stadaas JO (1986) Effects on peritoneal proteolysis and hemodynamics of prophylactic infusion with C1 inhibitor in experimental acute pancreatitis. Scand J Gastroenterol 21:1018\u20131024","journal-title":"Scand J Gastroenterol"},{"key":"1_CR107","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/gut.45.5.733","volume":"45","author":"DT Schneider","year":"1999","unstructured":"Schneider DT, Nurnberger W, Stannigel H, Bonig H, Gobel U (1999) Adjuvant treatment of severe acute pancreatitis with C1 esterase inhibitor concentrate after haematopoietic stem cell transplantation. Gut 45:733\u2013736","journal-title":"Gut"},{"key":"1_CR108","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0016-5107(95)70126-5","volume":"42","author":"PA Testoni","year":"1995","unstructured":"Testoni PA, Cicardi M, Bergamaschini L, Guzzoni S, Cugno M, Buizza M et al (1995) Infusion of C1-inhibitor plasma concentrate prevents hyperamylasemia induced by endoscopic sphincterotomy. Gastrointest Endosc 42:301\u2013305","journal-title":"Gastrointest Endosc"},{"key":"1_CR109","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/02841859709172102","volume":"38","author":"R Mikkonen","year":"1997","unstructured":"Mikkonen R, Aronen HJ, Kivisaari L, Piilonen A, Syrjala M (1997) Plasma levels of prekallikrein, alpha-2-macroglobulin and C1-esterase inhibitor in patients with urticarial reaction to contrast media. Acta Radiol 38:466\u2013473","journal-title":"Acta Radiol"},{"key":"1_CR110","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00004424-199609000-00008","volume":"31","author":"HM Hoffmeister","year":"1996","unstructured":"Hoffmeister HM, Heller W (1996) Radiographic contrast media and the coagulation and complement systems [see comments]. Invest Radiol 31:591\u2013595","journal-title":"Invest Radiol"},{"key":"1_CR111","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/028418519203300418","volume":"33","author":"HJ Aronen","year":"1992","unstructured":"Aronen HJ, Kivisaari L, Torstila I, Paavonen T, Meri S, Karonen SL et al (1992) Level of plasma prekallikrein and its inhibitors in reactors and nonreactors during intravenous enhancement with contrast media. Acta Radiol 33:374\u2013378","journal-title":"Acta Radiol"},{"key":"1_CR112","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00004424-198706000-00008","volume":"22","author":"JJ Hagan","year":"1987","unstructured":"Hagan JJ, Yost FJ, Nickoloff EL (1987) Prekallikrein activation, C1 esterase inhibitor, and factor XII as predictors of adverse reaction to contrast media. A prospective study. Invest Radiol 22:490\u2013494","journal-title":"Invest Radiol"},{"key":"1_CR113","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000233975","volume":"79","author":"KP Mathews","year":"1986","unstructured":"Mathews KP, Pan PM, Amendola MA, Lewis FH (1986) Plasma protease inhibitor and anaphylatoxin inactivator levels in chronic urticaria\/angioedema and in patients experiencing anaphylactoid reactions to radiographic contrast media. Int Arch Allergy Appl Immunol 79:220\u2013223","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"1_CR114","first-page":"185","volume":"8","author":"HT Johansen","year":"1986","unstructured":"Johansen HT, Hoem NO, Veggeland T, Briseid K (1986) Assay of kallikrein inhibitors and levels of acetone-activated kallikrein in plasma specimens from reactors to dextran or to contrast media. Int J Tissue React 8:185\u2013192","journal-title":"Int J Tissue React"},{"key":"1_CR115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0091-6749(79)90043-5","volume":"64","author":"EC Lasser","year":"1979","unstructured":"Lasser EC, Lang JH, Lyon SG, Hamblin AE (1979) Complement and contrast material reactors. J Allergy Clin Immunol 64:105\u2013112","journal-title":"J Allergy Clin Immunol"},{"key":"1_CR116","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/0091-6749(86)90411-2","volume":"77","author":"M Gardinali","year":"1986","unstructured":"Gardinali M, Cicardi M, Frangi D, Franzinelli M, Gattoni F, Uslenghi C et al (1986) In vivo study of the complement system during infusion of radiographic contrast media. J Allergy Clin Immunol 77:690\u2013692","journal-title":"J Allergy Clin Immunol"},{"key":"1_CR117","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0002-9343(60)90018-8","volume":"29","author":"B Clarkson","year":"1960","unstructured":"Clarkson B, Thompson D, Horwith M, Luckey EH (1960) Cyclical edema and shock due to increased capillary permeability. Am J Med 29:193\u2013216","journal-title":"Am J Med"},{"key":"1_CR118","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0161-5890(99)00048-6","volume":"36","author":"M Kirschfink","year":"1999","unstructured":"Kirschfink M, Nurnberger W (1999) C1 inhibitor in anti-inflammatory therapy: from animal experiment to clinical application. Mol Immunol 36:225\u2013232","journal-title":"Mol Immunol"},{"key":"1_CR119","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1128\/IAI.66.11.5350-5356.1998","volume":"66","author":"JA Hazelzet","year":"1998","unstructured":"Hazelzet JA, de Groot R, van Mierlo G, Joosten KF, van der Voort E, Eerenberg A et al (1998) Complement activation in relation to capillary leakage in children with septic shock and purpura. Infect Immun 66:5350\u20135356","journal-title":"Infect Immun"},{"key":"1_CR120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s001340000704","volume":"27","author":"B Stiller","year":"2001","unstructured":"Stiller B, Sonntag J, Dahnert I, Alexi-Meskishvili V, Hetzer R, Fischer T et al (2001) Capillary leak syndrome in children who undergo cardiopulmonary bypass: clinical outcome in comparison with complement activation and C1 inhibitor. Intensive Care Med 27:193\u2013200","journal-title":"Intensive Care Med"},{"key":"1_CR121","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1097\/00003246-200009000-00018","volume":"28","author":"A Radke","year":"2000","unstructured":"Radke A, Mottaghy K, Goldmann C, Khorram-Sefat R, Kovacs B, Janssen A et al (2000) C1 inhibitor prevents capillary leakage after thermal trauma. Crit Care Med 28:3224\u20133232","journal-title":"Crit Care Med"},{"key":"1_CR122","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0022-5223(96)70053-3","volume":"112","author":"MC Seghaye","year":"1996","unstructured":"Seghaye MC, Grabitz RG, Duchateau J, Busse S, Dabritz S, Koch D et al (1996) Inflammatory reaction and capillary leak syndrome related to cardiopulmonary bypass in neonates undergoing cardiac operations. J Thorac Cardiovasc Surg 112:687\u2013697","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1_CR123","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00024382-200004000-00006","volume":"13","author":"A Heller","year":"2000","unstructured":"Heller A, Kunz M, Samakas A, Haase M, Kirschfink M, Koch T (2000) The complement regulators C1 inhibitor and soluble complement receptor 1 attenuate acute lung injury in rabbits. Shock 13:285\u2013290","journal-title":"Shock"},{"key":"1_CR124","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1212\/WNL.53.1.220","volume":"53","author":"S Schmidt","year":"1999","unstructured":"Schmidt S, Hertfelder HJ, von Spiegel T, Hering R, Harzheim M, Lassmann H et al (1999) Lethal capillary leak syndrome after a single administration of interferon beta-1b. Neurology 53:220\u2013222","journal-title":"Neurology"},{"key":"1_CR125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s002770050321","volume":"75","author":"W Nurnberger","year":"1997","unstructured":"Nurnberger W, Heying R, Burdach S, Gobel U (1997) C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation. Ann Hematol 75:95\u2013101","journal-title":"Ann Hematol"},{"key":"1_CR126","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF01697978","volume":"71","author":"C Salat","year":"1995","unstructured":"Salat C, Holler E, Schleuning M, Eisele B, Reinhardt B, Kolb H et al (1995) Levels of the terminal complement complex, C3a-desArg and C1-inhibitor in adult patients with capillary leak syndrome following bone marrow transplantation. Ann Hematol 71:271\u2013274","journal-title":"Ann Hematol"},{"key":"1_CR127","first-page":"335","volume":"388","author":"CE Hack","year":"1994","unstructured":"Hack CE, Ogilvie AC, Eisele B, Jansen PM, Wagstaff J, Thijs LG (1994) Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy. Prog Clin Biol Res 388:335\u2013357","journal-title":"Prog Clin Biol Res"},{"key":"1_CR128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF01709661","volume":"67","author":"W Nurnberger","year":"1993","unstructured":"Nurnberger W, Michelmann I, Petrik K, Holthausen S, Willers R, Lauermann G et al (1993) Activity of C1 esterase inhibitor in patients with vascular leak syndrome after bone marrow transplantation. Ann Hematol 67:17\u201321","journal-title":"Ann Hematol"},{"key":"1_CR129","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1007\/BF01738946","volume":"19","author":"CE Hack","year":"1993","unstructured":"Hack CE, Ogilvie AC, Eisele B, Eerenberg AJ, Wagstaff J, Thijs LG (1993) C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Intensive Care Med 19:S19\u2013S28","journal-title":"Intensive Care Med"},{"key":"1_CR130","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/0140-6736(92)91564-O","volume":"339","author":"W Nurnberger","year":"1992","unstructured":"Nurnberger W, Gobel U, Stannigel H, Eisele B, Janssen A, Delvos U (1992) C1-inhibitor concentrate for sepsis-related capillary leak syndrome. Lancet 339:990","journal-title":"Lancet"}],"container-title":["Springer Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-005-0001-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-005-0001-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-005-0001-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T08:28:41Z","timestamp":1736065721000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-005-0001-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":130,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["1"],"URL":"https:\/\/doi.org\/10.1007\/s00281-005-0001-4","relation":{},"ISSN":["0344-4325","1432-2196"],"issn-type":[{"value":"0344-4325","type":"print"},{"value":"1432-2196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}